Heart:房颤类型与心律失常进展和临床结局相关!

2018-03-19 xing.T MedSci原创

由此可见,基线时永久性房颤与心力衰竭有关。相当一部分管理良好的房颤患者显示1年内存在房颤进展。房颤进展本身并不与结局密切相关,这表明可能需要改进目前的房颤分型以提高临床实用性。

房颤(AF)类型以及早期形态向永久性房颤进展的决定因素与结局之间的关系仍然知之甚少。

近日,在心脏病领域权威杂志Heart上发表了一篇研究文章,研究人员评估了房颤类型(阵发性、持续性和永久性),房颤进展的发生率和预测因子,以及房颤患者结局。研究人员对PREFER(预防血栓栓塞事件)研究中房颤延长数据集(n = 3223例房颤患者,完成了1年的随访,平均年龄为72±9岁,女性占40%)进行了主要分析。在PREFER房颤研究中进行了敏感性分析(n = 6390例患者)。

该研究中有506例(17%)患者进展为永久性房颤,与阵发性房颤相比,永久性房颤与1年时心力衰竭发生相关(比值比为1.80,95%可信区间为1.06-3.07,P = 0.03),并且在整个队列中得到了证实。在多变量调整模型中,基线窦性心律、房颤持续时间、心脏复律、甲亢、瓣膜性心脏病、糖尿病和心力衰竭是房颤进展的预测因子(受试者工作特征曲线下面积为0.60,95%可信区间为0.57-0.63)。当研究人员限制于房颤病程<1年的患者时,结果相似。房颤进展与1年内冠脉事件之间存在相关性(比值比为2.27,95%可信区间为1.22-4.19,P = 0.0074)。

由此可见,基线时永久性房颤与心力衰竭有关。相当一部分管理良好的房颤患者显示1年内存在房颤进展。房颤进展本身并不与结局密切相关,这表明可能需要改进目前的房颤分型以提高临床实用性。

原始出处:


Renate B Schnabel,et al. Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes. Heart. 2018. http://dx.doi.org/10.1136/heartjnl-2017-312569

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1843159, encodeId=c2151843159c1, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Aug 10 07:39:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356741, encodeId=58bf1356e4170, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 21 03:39:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562875, encodeId=ac0d15628e50d, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Mar 21 03:39:00 CST 2018, time=2018-03-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1843159, encodeId=c2151843159c1, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Aug 10 07:39:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356741, encodeId=58bf1356e4170, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 21 03:39:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562875, encodeId=ac0d15628e50d, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Mar 21 03:39:00 CST 2018, time=2018-03-21, status=1, ipAttribution=)]
    2018-03-21 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1843159, encodeId=c2151843159c1, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Aug 10 07:39:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356741, encodeId=58bf1356e4170, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 21 03:39:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562875, encodeId=ac0d15628e50d, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Mar 21 03:39:00 CST 2018, time=2018-03-21, status=1, ipAttribution=)]
    2018-03-21 slcumt